UnitedHealth Group (NYSE:UNH) Releases Earnings Results, Beats Expectations By $0.55 EPS

UnitedHealth Group (NYSE:UNH) released its earnings results on Tuesday. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.14 by $0.55, reports. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business had revenue of $112.70 billion for the quarter, compared to analyst estimates of $111.31 billion. During the same quarter in the prior year, the company posted $2.59 earnings per share. UnitedHealth Group’s revenue was down .4% on a year-over-year basis. UnitedHealth Group updated its FY 2026 guidance to 20.500- EPS.

Here are the key takeaways from UnitedHealth Group’s conference call:

• Third-quarter results improved materially, with revenue of $113 billion, adjusted EPS of $4.69 versus $2.92 a year ago, and a consolidated medical care ratio of 88.4% versus 89.9%.
• UnitedHealth raised its 2026 adjusted EPS outlook to at least $20.50 and said it views the result as a solid base for returning to its 13%-16% long-term growth target, while repurchasing $5 billion of stock through the third quarter.
• Medicare Advantage and Medicaid showed improving performance. Medicare margins are now expected near the top of the 2%-4% range, while Medicaid margins are projected to be moderately better than negative 1% for 2026, with further recovery targeted in 2027 and 2028.
• Medical costs remain elevated, particularly in commercial insurance, specialty pharmacy, acute care, and behavioral health. Commercial benefit trends are running above 11%, with No Surprises Act arbitration awards and clinician pricing pressure adding significant cost and delaying margin recovery.
• Management highlighted growing benefits from AI, modernization, and integrated value-based care, including reduced chart-review and appeal-processing times, fewer prior authorizations, and new Optum Insight AI products. However, additional technology and workflow investments will weigh on Optum Health’s fourth-quarter results as the company builds toward its 6%-8% margin target.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $396.02 on Thursday. The business’s 50 day moving average price is $387.10 and its two-hundred day moving average price is $383.47. The company has a market cap of $355.46 billion, a PE ratio of 22.62, a price-to-earnings-growth ratio of 1.41 and a beta of 0.60. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. UnitedHealth Group has a twelve month low of $255.96 and a twelve month high of $461.62.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were issued a dividend of $2.32 per share. The ex-dividend date was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 59.72%.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported adjusted earnings of $4.69 per share, above the approximately $4.14 consensus estimate, while revenue of $112.7 billion also exceeded expectations. Operating earnings increased 52% to $6.6 billion, supporting confidence in the company’s turnaround. UnitedHealth Group Shares Gap Up Following Strong Earnings
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $20.50 per share, above its prior $19.50-to-$20.00 range and analyst expectations. The company also indicated that 2027 growth could be stronger than current Wall Street forecasts. UnitedHealth Group Stock Jumps on Profit Outlook Raise
• Positive Sentiment: Improved medical cost management helped the medical care ratio reach 88.4%. Investors were encouraged by better profitability across UnitedHealthcare and Optum, as well as management’s expectation that Medicaid margins will begin improving after 2026. UnitedHealth Group Gains After Q3 Beat and Higher Outlook
• Positive Sentiment: Analyst sentiment remains broadly constructive. Piper Sandler raised its target to $504 and maintained an overweight rating, while Mizuho named UNH a top healthcare pick; several targets imply substantial upside from recent levels. UnitedHealth Stock Moves Higher

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on UNH. Cantor Fitzgerald raised their price target on UnitedHealth Group from $440.00 to $495.00 and gave the company an “overweight” rating in a research note on Friday, July 17th. Piper Sandler upped their price objective on UnitedHealth Group from $502.00 to $504.00 and gave the stock an “overweight” rating in a research note on Wednesday. TD Cowen cut their price objective on UnitedHealth Group from $430.00 to $402.00 and set a “hold” rating for the company in a report on Friday, October 9th. Barclays decreased their target price on shares of UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating for the company in a research note on Wednesday. Finally, Zacks Research downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Monday, September 14th. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $461.83.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.19% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.